PC(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))

Term ID

CHEBI:88878

Synonyms

(2-{[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Arachidonoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine
GPCho(20:4/16:1)
GPCho(20:4n6/16:1n7)
GPCho(20:4w6/16:1w7)
GPCho(36:5)
Lecithin
PC aa C36:5
PC(20:4/16:1)
PC(20:4n6/16:1n7)
PC(20:4w6/16:1w7)
PC(36:5)
Phosphatidylcholine(20:4/16:1)
Phosphatidylcholine(20:4n6/16:1n7)
Phosphatidylcholine(20:4w6/16:1w7)
Phosphatidylcholine(36:5)

(all 16)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))

Phenotype where environments contain PC(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))

Phenotype modified by environments containing PC(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))

Phenotype affecting PC(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))

Human Disease Model